InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Wendel Bruce, Director. Director active across 1 companies, notably GT Biopharma, Inc.. Aggregated, 2 disclosures have been logged. Total volume traded: €17k. The latest transaction was disclosed on 16 November 2020 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€8,6633,268 shares@ €2.6509100.0% of flow
Common Stock
SEC:0001654954-21-010887·
Ideal exit: 13 Aug 2021 (T+270)
€8,6633,268 shares@ €2.65090.043% mcap50.0% of flow
Common Stock
SEC:0001654954-21-010887:0·
Ideal exit: 13 Aug 2021 (T+270)
2 of 2 declarations
About Wendel Bruce
Bruce Wendel is a Director at GT Biopharma, Inc. In this role, he brings his expertise to guide the company's strategy and participate in key board decisions.
